APPILI THERAPEUTICS INC-CL A (APLI.CA)
CA03783R1073 - Common Stock
| MRQ (2024-9-30) | 2024 (2024-3-31) | 2023 (2023-3-31) | 2022 (2022-3-31) | 2021 (2021-3-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 665.22K | 94.49K | 2.47M | 6.66M | 11.06M | |||
| Cash Equivalents | N/A | N/A | N/A | 6.66M | N/A | |||
| Marketable Securities | N/A | N/A | N/A | 0.00 | 5.06M | |||
| Receivables | 750.68K | 1.17M | 420.00K | 1.39M | 1.69M | |||
| Inventories | N/A | N/A | N/A | N/A | 0.00 | |||
| Other Current Assets | 112.69K | 192.43K | 230.00K | 180.00K | 450.00K | |||
| Total Current Assets | 1.53M | 1.46M | 3.12M | 8.24M | 18.26M | |||
| Non-Current Assets | ||||||||
| PPE Net | 25.62K | 30.14K | 10.00K | 40.00K | 50.00K | |||
| Total Non-Current Assets | 25.63K | 30.14K | 10.00K | 40.00K | 60.00K | |||
| TOTAL ASSETS | 1.55M | 1.49M | 3.13M | 8.28M | 18.32M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 9.61M | 7.31M | 110.00K | 100.00K | 90.00K | |||
| Accrued Expenses | N/A | N/A | N/A | 74.00K | N/A | |||
| Accounts Payable | 4.21M | 4.18M | 2.82M | 6.46M | 4.53M | |||
| Other Current Liabilities | 42.50K | 47.15K | 40.00K | 120.00K | N/A | |||
| Total Current Liabilities | 13.86M | 11.54M | 2.98M | 6.67M | 4.62M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 814.10K | 875.20K | 7.55M | 4.88M | 950.00K | |||
| Total Non-Current Liabilities | 814.10K | 875.20K | 7.55M | 4.88M | 940.00K | |||
| TOTAL LIABILITIES | 14.67M | 12.42M | 10.53M | 11.55M | 5.56M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -68.59M | -66.12M | -56.13M | -47.94M | -24.76M | |||
| Additional Paid In Capital | 13.15M | 12.87M | 6.41M | 5.01M | 2.55M | |||
| Common Shares | 42.32M | 42.32M | 42.32M | 39.65M | 34.96M | |||
| Other Shareholders' Equity | N/A | N/A | N/A | 8.13M | N/A | |||
| Shares Outstanding | 121.27M | 121.27M | 121.27M | 71.27M | 62.78M | |||
| Tangible Book Value per Share | -0.11 | -0.09 | -0.06 | -0.05 | 0.20 | |||
| Total Shareholders' Equity | -13.12M | -10.92M | -7.40M | -3.27M | 12.75M | |||
| TOTAL LIABILITIES AND EQUITY | 1.55M | 1.49M | 3.13M | 8.28M | 18.32M | |||
| Statistics | ||||||||
| Debt/Equity | -0.06 | -0.08 | -1.02 | -1.49 | 0.07 | |||
| Current Ratio | 0.11 | 0.13 | 1.05 | 1.24 | 3.95 | |||
| Return On Assets (ROA) | -230.61% | -253.68% | -295.21% | -303.38% | -78.22% | |||
| Return On Equity (ROE) | N/A | N/A | N/A | N/A | -112.39% | |||
All data in CAD , ROIC based on taxRate of 0.28